Results
|
|
1781.
|
|
|
|
1782.
|
|
|
|
1783.
|
|
|
|
1784.
|
|
|
|
1785.
|
|
|
|
1786.
|
|
|
|
1787.
|
A phase I pharmacodynamic study of GTI-2040, an antisense oligonucleotide against ribonuclotide reductase, in acute leukemias: a California Cancer Consortium study. [electronic resource] by
- Kirschbaum, Mark H
- Frankel, Paul
- Synold, Timothy W
- Xie, Zhiliang
- Yen, Yun
- Popplewell, Leslie
- Chen, Robert
- Aljitawi, Omar
- Tuscano, Joseph M
- Chan, Kenneth K
- Newman, Edward M
Producer: 20171222
In:
Leukemia & lymphoma vol. 57
Availability: No items available.
|
|
|
1788.
|
|
|
|
1789.
|
|
|
|
1790.
|
|
|
|
1791.
|
|
|
|
1792.
|
|
|
|
1793.
|
|
|
|
1794.
|
|
|
|
1795.
|
Potent competitive inhibition of human ribonucleotide reductase by a nonnucleoside small molecule. [electronic resource] by
- Ahmad, Md Faiz
- Alam, Intekhab
- Huff, Sarah E
- Pink, John
- Flanagan, Sheryl A
- Shewach, Donna
- Misko, Tessianna A
- Oleinick, Nancy L
- Harte, William E
- Viswanathan, Rajesh
- Harris, Michael E
- Dealwis, Chris Godfrey
Producer: 20180518
In:
Proceedings of the National Academy of Sciences of the United States of America vol. 114
Availability: No items available.
|
|
|
1796.
|
|
|
|
1797.
|
|
|
|
1798.
|
|
|
|
1799.
|
|
|
|
1800.
|
|